Literature DB >> 6578477

Oral presentations in non-Hodgkin's lymphoma: a review of thirty-one cases. Part I. Data analysis.

L Eisenbud, J Sciubba, R Mir, S A Sachs.   

Abstract

Thirty-one patients with oral manifestations of non-Hodgkin's lymphoma have been studied with reference to age, sex, race, location of lesion in oral cavity, stage of disease on presentation, duration of disease at time of presentation, histologic type, modes of treatment, and survival. There were 6 children and 25 adults, ranging in age from 3 to 89 years. Only 2 of the 31 patients were black. Sex incidence was almost equal, with 17 females and 14 males. In 12 cases the oral findings alone represented the initial presentation of lymphoma. The maxilla, mandible, and palate accounted for 24 of the 31 cases. The preponderance of diffuse histologic patterns was striking (77.4 percent). Eighteen cases (58.0 percent) presented in Stage I or Stage II, indicating relatively limited extent of disease. More generalized involvement was found in the remaining thirteen cases (41.9 percent). Thus, although NHL may appear in the oral region as the first detected evidence of disease, in many patients a work-up will show that the process is widespread in distribution. In this brief series survival data coincide with the established principles that a poorer prognosis is associated with the diffuse histologic pattern, as well as certain identified histiocytic and poorly differentiated lymphocytic subtypes.

Entities:  

Mesh:

Year:  1983        PMID: 6578477     DOI: 10.1016/0030-4220(83)90281-5

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  9 in total

1.  Non-Hodgkin's lymphoma manifest as gingival hyperplasia in a renal transplant recipient.

Authors:  Jung Hyun Kwon; Joon Chang Song; Sang Hun Lee; So Young Lee; Chul Woo Yang; Yong Soo Kim; Byung Kee Bang
Journal:  Korean J Intern Med       Date:  2005-12       Impact factor: 2.884

2.  [Initial diagnosis of malignant lymphomas with manifestations in the mouth cavity and adjacent tissues].

Authors:  S Colbow; B Langanke; U Teuber
Journal:  Mund Kiefer Gesichtschir       Date:  1997-02

3.  Diffuse swelling of the buccal mucosa and palate as first and only manifestation of an extranodal non-Hodgkin 'double-hit' lymphoma: report of a case.

Authors:  Marc Frei; Patrick Dubach; Peter A Reichart; Anja M Schmitt; Esther Mueller-Garamvölgyi; Michael M Bornstein
Journal:  Oral Maxillofac Surg       Date:  2010-10-28

4.  HIV-associated large aggressive extranodal lymphoma of the oral cavity.

Authors:  Rahul Dilip Kamat; Vikas Dhupar; Francis Akkara; Anita Dhupar
Journal:  Natl J Maxillofac Surg       Date:  2016 Jul-Dec

5.  Gastrointestinal tract metastasis of mandibular diffuse large B-cell lymphoma.

Authors:  Turker Yucesoy; Erdem Kilic; Hakan Ocak; Alper Alkan; Kemal Deniz
Journal:  Clin Case Rep       Date:  2018-07-10

6.  Primary Nasopharyngeal non-Hodgkin lymphomas: a retrospective review of 26 Moroccan patients.

Authors:  Wafa Allam; Nabil Ismaili; Sanaa Elmajjaoui; Bel K Elgueddari; Mohammed Ismaili; Hassan Errihani
Journal:  BMC Ear Nose Throat Disord       Date:  2009-11-17

7.  Primary non-Hodgkin's lymphoma of gingiva in a 28-year-old HIV-positive patient.

Authors:  K F Basavaraj; Karthikeyan Ramalingam; Amitabha Sarkar; Savitha Muddaiah
Journal:  J Nat Sci Biol Med       Date:  2012-07

8.  Malignant lymphoma of the oral cavity and the maxillofacial region: overall survival prognostic factors.

Authors:  Janet-Ofelia Guevara-Canales; Rafael Morales-Vadillo; Sonia-Julia Sacsaquispe-Contreras; Carlos Barrionuevo-Cornejo; Jaime Montes-Gil; Carlos-Enrique Cava-Vergiú; Fernando-Augusto Soares; Henrique-Duque-de-Miranda Chaves-Netto; Maria-das-Graças-Afonso-Miranda Chaves
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-07-01

9.  Oral Malignant Non-Hodgkin Lymphoma: A Retrospective Single-Center Study.

Authors:  Selene Barone; Caterina Buffone; Martina Ferrillo; Federica Pasqua; Stefano Parrotta; Marianna Salviati; Francesco Bennardo; Alessandro Antonelli
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.